Four months after the World Health Organization declared it a pandemic, COVID-19 remains at the forefront of the global health agenda and will likely continue to be in the foreseeable future. But this acute global challenge hasnt displaced the long-term problems plaguing health systems worldwide increasing rates of multiple chronic diseases, rising drug development costs and inefficient, unsustainable and prohibitively expensive healthcare delivery models. Indeed, the pandemic has only accentuated and exacerbated these pre-existing conditions.
Ignoring or downplaying these longer-standing issues wont help countries effectively combat the current health crisis and are only a recipe for ensuring more crises down the line. Researchers, clinicians, entrepreneurs, business leaders and governments must therefore adopt a two-pronged approach, investing in innovative solutions for addressing both near- and long-term healthcare challenges.
This will entail nothing short of a revolution in medical treatment and Bio-convergence is poised to play a major role in making it happen. Bio-convergence represents a 21st-century approach to problem-solving, an upcoming technological wave with the potential to revolutionize the digital health industry, as well as many other sectors.
What exactly is Bio-convergence? The nascent field fuses life sciences with different technologies from mathematics, engineering, and the physical and computational sciences, creating a sum far greater than its parts. Indeed, the human body is an incredibly complex organism made up of countless intricate systems, so it makes perfect sense that treating it must be multidisciplinary and multifaceted. Enabled by advances in genomics, gene therapy, DNA sequencing, artificial intelligence, big data, nanotechnology, and synthetic biology, Bio-convergence is paving such a holistic path to remarkable innovations in treatment, discovery and delivery, regenerative medicine, and diagnostics, with potential benefits for COVID-19 and well beyond.
It is exactly this tremendous potential for improving healthcare across the board and in the process bettering lives which has led the Israel Innovation Authority, Israels public agency for promoting innovation at all levels, to spearhead efforts to turn the country into a hub of Bio-convergence endeavor and invention.
Bio-Convergence and the Healthcare Landscape
The Bio-convergence opportunity coincides with a crisis moment in the global health system. While breakthroughs in medical research and treatment have increased global life expectancy at birth from 52.6 years in 1960 to 72.6 years in 2018, aging populations and rising rates of chronic conditions like cancer, heart disease, and diabetes have sent healthcare costs surging.
By 2022, global health expenditure will surpass $10 trillion. That spending tends to be disproportionately devoted to managing chronic illness: In the U.S., for instance, nearly 60% of adults have at least one chronic condition, and these individuals account for 90% of healthcare spending overall, according to the Rand Corporation.
Improving outcomes for patients with chronic illnesses while also controlling costs hinges on early, effective, and personalized intervention and thats precisely what Bio-convergence aims to make possible.
How Israel Is Propelling Bio-Convergence Forward
In theory, its clear why Israel is well-positioned to lead the Bio-convergence revolution. With approximately 1,600 active life sciences companies, unparalleled expertise in fields from AI to digital health to nanotechnology, and some of the worlds leading universities, research centers, and hospital systems, the Start-Up Nation is incubating some of the most promising developments in Bio-convergence.
Ranked fifth in the world in patents per capita, the country has the worlds second-largest centralized electronic health records system and is home to more than 600 active medical device companies, 500 AI-driven healthcare companies, and R&D centers established by major multinational companies like Medtronic, Philips, GE, and more. Israels medical, engineering, and scientific knowhow can fairly be described as an excellent fit for Bio-convergence, with healthcare systems and patients alike standing to gain big.
And in practice? Israeli-developed innovations in Bio-convergence are attracting global attention. Consider the case of BiomX, which combines synthetic biology with an advanced AI platform to develop innovative microbiome-based therapeutics which aim at preventing and treating cancer, skin disorders, and other medical conditions. BiomX is a publicly traded company which offers a complete end-to-end solution from target discovery to development of therapeutic compounds.
BiomX is part of an expanding ecosystem of Israeli companies and institutions operating in the field of Bio-convergence:
MeMed harnesses AI, systems engineering, and molecular biology to create a diagnostic platform to generate precise distinctions between bacterial and viral infections.
The Technions Lab for Cancer Drug Delivery & Cell-Based Technologies has developed nano-ghosts, a drug delivery system that delivers cancer drugs directly to cancerous cells, sparing surrounding healthy cells.
Such companies are continuing a longstanding Israeli tradition of biotechnological innovation. In 1996, the Weizmann Institute of Science developed Copaxone, the groundbreaking multiple sclerosis drug that reduces the frequency of relapses. In the 1970s, the Technion, in collaboration with Teva Pharmaceuticals, incubated Azilect, a drug used to treat Parkinsons Disease.
Notably, these breakthroughs were the product of multi-stakeholder, multidisciplinary collaborations bringing together academic researchers, technologists, and industry exemplifying the kind of cross-pollination at the heart of Bio-convergence.
Accelerating Innovation in Bio-Convergence
At the core of Israels early success in Bio-convergence is its world-renowned human capital. Unleashing the full potential of Israels human capital requires smart investments to support and accelerate promising technologies and cutting-edge solutions which is why over the past decade, the Israel Innovation Authority has invested more than $100 million annually in the life sciences sector across a number of different programs.
Through international cooperation agreements, R&D incentive programs targeting multinational corporations, and early-stage incubator programs, the Innovation Authority is propelling Bio-convergence forward for the benefit of humankind.
The innovations that will define the future of healthcare will transcend disciplines, relying on ingenuity and expertise across different domains. This outside-the-box approach gave rise to the Start-Up Nation and it has put Israel in a prime position to pioneer a new era of healthcare with this groundbreaking approach to human wellness.
Read the rest here:
Israel Is Spearheading a 'Bio-Convergence' Revolution | Anya Eldan - The Times of Israel
- Electronic Materials Company Cambrios Announces Closing $14.5 Million Round - November 8th, 2009 [November 8th, 2009]
- Europe's 'Extreme light infrastructure' project gears up for launch - November 8th, 2009 [November 8th, 2009]
- Industrial nanotechnology processes getting closer - November 8th, 2009 [November 8th, 2009]
- Konsultation zum Austria Nano-Aktionsplan - November 8th, 2009 [November 8th, 2009]
- Bewegungen von Viren auf Membranen live verfolgen - November 8th, 2009 [November 8th, 2009]
- Thailand Nanotechnology Conference on health, energy, environment - November 8th, 2009 [November 8th, 2009]
- Samsung Intensifies Advanced Foundry Logic Process Development with New Semiconductor Research Center - November 8th, 2009 [November 8th, 2009]
- Infineon and TSMC to Jointly Develop 65nm Embedded Flash Process Technology For Automotive and Chip Card Applications - November 8th, 2009 [November 8th, 2009]
- Abraxis Health Dedicates State of the Art Nanotechnology and Biologics Facility in Phoenix, Arizona - November 8th, 2009 [November 8th, 2009]
- Beneq Announces The First Continous Mode Atomic Layer Deposition Research Tool - November 8th, 2009 [November 8th, 2009]
- An electron microscope with glasses - November 8th, 2009 [November 8th, 2009]
- Give your opinion on the Nanotechnology Research Code of Conduct - November 8th, 2009 [November 8th, 2009]
- Presentations from the OECD Conference on the Potential Environmental Benefits of Nanotechnology - November 8th, 2009 [November 8th, 2009]
- DFI Nanotechnology Expands Into China With Strategic Alliance in Hong Kong - November 8th, 2009 [November 8th, 2009]
- Pre-announcement: Call for proposals within 'Energy Efficiency with Nanotechnology' - November 8th, 2009 [November 8th, 2009]
- This week in nanotechnology - November 8th, 2009 [November 8th, 2009]
- New funding for development and deployment of UAlbany nanofabrication strategies - November 8th, 2009 [November 8th, 2009]
- Applied Materials Acquires the Assets of Advent Solar - November 8th, 2009 [November 8th, 2009]
- Advanced Researcher Grant 2009 an Nanowissenschaftlerin Luisa de Cola - November 8th, 2009 [November 8th, 2009]
- Ocean Optics Launches Dedicated OEM Website - November 8th, 2009 [November 8th, 2009]
- New synthetic molecules trigger immune response to HIV and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Computer predicts reactions between molecules and surfaces, with 'chemical precision' - November 8th, 2009 [November 8th, 2009]
- Austria showcases its nanotechnology initiative - November 8th, 2009 [November 8th, 2009]
- Nanocapsules for artificial photosynthesis - November 8th, 2009 [November 8th, 2009]
- Work begins on laboratory for world's strongest microscope - November 8th, 2009 [November 8th, 2009]
- New cancer detection method with fluorescent silica beads - November 8th, 2009 [November 8th, 2009]
- Die Magnetisierung einzelner Atome manipulieren - November 8th, 2009 [November 8th, 2009]
- Novel nanoparticles could become a safer alternative to gene therapy delivered by viruses - November 8th, 2009 [November 8th, 2009]
- DOE awards Argonne, partners more than $7 million for solar energy-related research projects - November 8th, 2009 [November 8th, 2009]
- Magnetic nanoparticles to simultaneously diagnose, monitor and treat - November 8th, 2009 [November 8th, 2009]
- Study of ultracold atoms proves theory about universal quantum mechanism - December 13th, 2009 [December 13th, 2009]
- RUSNANO Supervisory Council approves nanostructured non-metallic coatings project - December 13th, 2009 [December 13th, 2009]
- Julian Wess Award for outstanding achievements in elementary particle and astroparticle physics - December 13th, 2009 [December 13th, 2009]
- New Pegasus300 Sold to Leading French Research Institute for CMOS Packaging - December 13th, 2009 [December 13th, 2009]
- Soitec Expands Into the Fast Growing Solar Energy Market With the Acquisition of Concentrix Solar - December 13th, 2009 [December 13th, 2009]
- Students send microbe nanobiotechnology experiment on Space Shuttle Atlantis - December 13th, 2009 [December 13th, 2009]
- Photovoltaic cells to power biological nanorobots inside the body - December 13th, 2009 [December 13th, 2009]
- Environmental and human health impacts of nanotechnology - December 13th, 2009 [December 13th, 2009]
- Elusive 'hot' electrons captured in ultra-thin solar cells - December 13th, 2009 [December 13th, 2009]
- Light-generating transistors to power labs on chips - December 13th, 2009 [December 13th, 2009]
- Combining rare-earth clusters with traditional metal catalysts reveals secrets of chemical transformation - December 13th, 2009 [December 13th, 2009]
- Hexagon Expands Its Offering in the Vision Metrology Business - December 13th, 2009 [December 13th, 2009]
- Azaya Therapeutics Receives FDA Authorization to Start Phase I Cancer Trial - December 13th, 2009 [December 13th, 2009]
- Researchers engineer bacteria to turn carbon dioxide into liquid fuel - December 13th, 2009 [December 13th, 2009]
- Argonne creates green home for world-class nanotechnology research - December 13th, 2009 [December 13th, 2009]
- The mechanism behind superinsulation may lead to new types of electronics - December 13th, 2009 [December 13th, 2009]
- Biosensors change color when they detect specific neural messages - December 14th, 2009 [December 14th, 2009]
- First measurement of cancer biomarkers in whole blood - December 14th, 2009 [December 14th, 2009]
- Nanoprobes hit targets in tumors, could lessen chemo side effects - December 14th, 2009 [December 14th, 2009]
- EYP/energy group joins UAlbany NanoCollege's National Institute for Sustainable Energy - December 14th, 2009 [December 14th, 2009]
- Scientists isolate new antifreeze molecule in Alaska beetle - December 14th, 2009 [December 14th, 2009]
- Ocean Optics XR-Series Spectrometers Cover 200-1050 nm Wavelengths - December 14th, 2009 [December 14th, 2009]
- All-in-one cancer-killing nanoparticle can be tracked in real time with MRI - December 14th, 2009 [December 14th, 2009]
- Nanobodies modifizieren die Form und Funktion von Proteinen - December 14th, 2009 [December 14th, 2009]
- Elias A. Zerhouni, M.D. to Join Leica Microsystems' Parent Company Board of Directors - December 14th, 2009 [December 14th, 2009]
- France to invest billions in nanotechnology - December 14th, 2009 [December 14th, 2009]
- AlphaRx Appoints President for its China Operations - December 14th, 2009 [December 14th, 2009]
- Vistec Enters Into Electron-Beam Lithograpy Project With Moscow University - December 14th, 2009 [December 14th, 2009]
- Record-breaking ultrasensitive spectrometer identifies trace gases in real time - December 14th, 2009 [December 14th, 2009]
- NanoMech Receives Navy Contract to Develop Nanotechnology Lubricant - December 14th, 2009 [December 14th, 2009]
- Heart cells display a behavior-guiding 'nanosense' on new lab-on-a-chip - December 14th, 2009 [December 14th, 2009]
- New curriculum mixes nanotechnology and skiing - December 14th, 2009 [December 14th, 2009]
- Rexahn and TheraTarget Form Nanotechnology Research Collaboration - December 14th, 2009 [December 14th, 2009]
- Unidym Enters Agreement to Integrate Carbon Nanotube Films Into LCDs - December 14th, 2009 [December 14th, 2009]
- Carl Zeiss Meditec Closes Financial Year on a High - December 14th, 2009 [December 14th, 2009]
- The Scott Partnership Appointed to Launch Innovative New Printed Electronics Business - December 14th, 2009 [December 14th, 2009]
- New Centre for Molecular Epidemiology to put bacteria on the world map - December 14th, 2009 [December 14th, 2009]
- New nanotechnology association established to address 21st century natural resource and energy security challenges - December 14th, 2009 [December 14th, 2009]
- Analysis of information gathering initiatives on manufactured nanomaterials - December 14th, 2009 [December 14th, 2009]
- OECD publishes manufactured nanomaterials roadmap 2010 - December 14th, 2009 [December 14th, 2009]
- New imaging technique allows quick evaluation of graphene sheets - December 14th, 2009 [December 14th, 2009]
- National Institute of Standards and Technology invests up to $71 million in new manufacturing, infrastructure research and development - December 16th, 2009 [December 16th, 2009]
- Southwest Nanotechnologies Recieves Two Prestigious Research Grants To Deveop A New Generation of Carbon Nanotubes - December 16th, 2009 [December 16th, 2009]
- Nanolithographic technique allows multiple chemicals on a single chip - December 16th, 2009 [December 16th, 2009]
- Study documents puzzling movement of electricity-producing bacteria near energy sources - December 16th, 2009 [December 16th, 2009]
- Erstmals Daten aus lebenden Zellen: Optisches Verfahren misst molekulare Reaktionszeiten - December 16th, 2009 [December 16th, 2009]
- New Constant Diameter NeedleProbes with Unique Ability to Measure Liquid Surface Properties by AFM - December 16th, 2009 [December 16th, 2009]
- Chemical Nanotechnology Talks X: Green nano - challenges of sustainability - December 16th, 2009 [December 16th, 2009]
- Patents Issued for Licensed PAL-M Super-resolution Technology - December 16th, 2009 [December 16th, 2009]
- International Network CONTACT researches the use of carbon nanotubes in various applications - December 16th, 2009 [December 16th, 2009]